Lipella Pharmaceuticals Inc
General ticker "LIPO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.2M
Lipella Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -41.3%.
Estimated limits based on current volatility of 5.5%: low 2.60$, high 2.90$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.94$, 9.80$]
- 2024-12-30 to 2025-12-30 estimated range: [1.96$, 6.49$]
Short-term LIPO quotes
Long-term LIPO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.26MM | $0.18MM | $0.45MM |
| Operating Expenses | $2.18MM | $2.77MM | $5.20MM |
| Operating Income | $-1.92MM | $-2.59MM | $-4.75MM |
| Non-Operating Income | $0.05MM | $-0.01MM | $0.13MM |
| Interest Expense | $0.01MM | $0.01MM | $0.01MM |
| R&D Expense | $1.46MM | $2.55MM | $3.04MM |
| Income(Loss) | $-1.87MM | $-2.60MM | $-4.62MM |
| Profit(Loss) | $-1.87MM | $-2.60MM | $-4.62MM |
| Stockholders Equity | $1.42MM | $4.68MM | $3.14MM |
| Inventory | $0.00MM | $0.11MM | $0.00MM |
| Assets | $2.01MM | $5.95MM | $3.58MM |
| Operating Cash Flow | $-0.99MM | $-1.83MM | $-3.15MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.01MM |
| Investing Cash Flow | $-0.30MM | $0.30MM | $-0.01MM |
| Financing Cash Flow | $2.10MM | $5.24MM | $1.34MM |
| Earnings Per Share* | $-0.33 | $-0.45 | $-0.77 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.